
Dr Lal Pathlabs Ltd Sees High-Value Trading Amid Institutional Interest and Positive Momentum
2026-09-16 10:00:13Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has emerged as one of the most actively traded stocks by value on 16 Sep 2026, reflecting strong institutional participation and sustained investor interest. Despite a marginal dip in price, the stock’s liquidity and trading volumes underscore its appeal among market participants.
Read full news article
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2035
2026-09-16 09:58:45With a decisive intraday surge to Rs 2035, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This achievement comes amid a backdrop of strong technical signals that have aligned to propel the stock beyond previous resistance levels.
Read full news article
Dr Lal Pathlabs Ltd is Rated Buy
2026-09-08 10:11:17Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 08 September 2026, providing investors with the most up-to-date view of the company’s performance and prospects.
Read full news article
Dr Lal Pathlabs Ltd is Rated Buy
2026-08-28 10:11:16Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Dr Lal Pathlabs Ltd is Rated Buy
2026-08-17 10:10:55Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1989.35
2026-08-12 09:55:08With a decisive surge to Rs 1989.35 on 12 Aug 2026, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to the broader market.
Read full news article
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1971.65
2026-08-10 10:14:08Surpassing the Rs 1970 mark for the first time, Dr Lal Pathlabs Ltd has reached a fresh 52-week high on 10 Aug 2026, propelled by a confluence of bullish technical indicators and sustained price momentum. This milestone caps a year-long rally that has delivered a 23.16% return, comfortably outpacing the Sensex’s decline of 1.83% over the same period.
Read full news article
Dr Lal Pathlabs Ltd is Rated Buy
2026-08-06 10:11:57Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 06 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1950.45
2026-08-04 09:49:03Surging past its previous peaks, Dr Lal Pathlabs Ltd touched a fresh 52-week high of Rs 1950.45 on 4 Aug 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
04-Sep-2026 | Source : BSEAttached
Announcement under Regulation 30 (LODR)-Updates on Acquisition
27-Aug-2026 | Source : BSEAttached
Incorporation Of A Step-Down Subsidiary Company
19-Aug-2026 | Source : BSEAttached
Corporate Actions
No Upcoming Board Meetings
Dr Lal Pathlabs Ltd has declared 50% dividend, ex-date: 30 Jul 26
No Splits history available
Dr Lal Pathlabs Ltd has announced 1:1 bonus issue, ex-date: 19 Dec 25
No Rights history available






